November 16, 2026
Business

Emcure slashes obesity drug Poviztra price by up to 55% amid competition(Soban News)

Emcure cuts Poviztra prices by up to 55% following Novo Nordisk’s move, lowering monthly treatment costs for semaglutide-based obesity therapy in India

​Emcure cuts Poviztra prices by up to 55% following Novo Nordisk’s move, lowering monthly treatment costs for semaglutide-based obesity therapy in India by Soban News (international And National News)

Related posts

Stocks to Watch, October 10: NTPC, Waaree Renewable Technologies, TCS, Tata Elxsi, Sona BLW, Indosolar, Signature Global, Blue Dart – Upstox(Soban News)

News-Soban-Admin

Govt may need ₹2,000 cr corpus to implement credit guarantee scheme(Soban News)

News-Soban-Admin

Dollar steady as markets brace for busy c.bank week amid Mideast war(Soban News)

News-Soban-Admin

Leave a Comment